SSTN-302

N/A

Report date: 2024/07/01 17:40:00
NME

Base Information

Drug NameSSTN-302
Drug Alias NameSSTN-302
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurogenic locus notch homolog protein 1 inhibitors
TargetsNeurogenic locus notch homolog protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStemSynergy Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesStemSynergy Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A